{"transactions":[{"id":755320,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":42482,"kind":"person","name":"Sabatini Brent","position":1,"cik":"0002037272","reported_name":"Sabatini Brent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Chief Accounting Officer"}}],"security":"Common  Stock","published_at":"2026-06-02T21:31:54.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":379,"price":9.45,"value":3581.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 379 shares of common stock acquired by the Reporting Person on May 29, 2026 pursuant to an employee stock purchase program."}],"balance_after":61902,"source":{"system":"sec-edgar","filing":"0001628280-26-039938","document":"wk-form4_1780435911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2037272/000162828026039938/wk-form4_1780435911.xml","form_type":"4"}},{"id":829568,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":42482,"kind":"person","name":"Sabatini Brent","position":1,"cik":"0002037272","reported_name":"Sabatini Brent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Chief Accounting Officer"}}],"security":"Common  Stock","published_at":"2026-03-24T20:35:36.000Z","date":"2026-03-23","kind":"sale","planned":true,"acquired":false,"shares":7711,"price":9.12,"value":70324.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025."}],"balance_after":61902,"source":{"system":"sec-edgar","filing":"0001628280-26-020823","document":"wk-form4_1774384534.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2037272/000162828026020823/wk-form4_1774384534.xml","form_type":"4"}},{"id":880017,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":42482,"kind":"person","name":"Sabatini Brent","position":1,"cik":"0002037272","reported_name":"Sabatini Brent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Chief Accounting Officer"}}],"security":"Common  Stock","published_at":"2026-02-26T21:56:06.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":1430,"price":9.5326,"value":13631.618,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an automatic and mandatory sale of shares under a  Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":69613,"source":{"system":"sec-edgar","filing":"0001628280-26-012396","document":"wk-form4_1772142963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2037272/000162828026012396/wk-form4_1772142963.xml","form_type":"4"}},{"id":885455,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":42482,"kind":"person","name":"Sabatini Brent","position":1,"cik":"0002037272","reported_name":"Sabatini Brent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Chief Accounting Officer"}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2026-02-25T00:13:34.000Z","date":"2026-02-22","kind":"grant","planned":true,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":7.56,"expiration_date":"2036-02-21","underlying":"Common  Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001628280-26-011331","document":"wk-form4_1771978411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2037272/000162828026011331/wk-form4_1771978411.xml","form_type":"4"}},{"id":885454,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":42482,"kind":"person","name":"Sabatini Brent","position":1,"cik":"0002037272","reported_name":"Sabatini Brent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Chief Accounting Officer"}}],"security":"Common  Stock","published_at":"2026-02-25T00:13:34.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":1829,"price":7.4528,"value":13631.1712,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents an automatic and mandatory sale of shares under a  Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.v"}],"balance_after":71043,"source":{"system":"sec-edgar","filing":"0001628280-26-011331","document":"wk-form4_1771978411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2037272/000162828026011331/wk-form4_1771978411.xml","form_type":"4"}},{"id":885453,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":42482,"kind":"person","name":"Sabatini Brent","position":1,"cik":"0002037272","reported_name":"Sabatini Brent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Chief Accounting Officer"}}],"security":"Common  Stock","published_at":"2026-02-25T00:13:34.000Z","date":"2026-02-22","kind":"grant","planned":true,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":72872,"source":{"system":"sec-edgar","filing":"0001628280-26-011331","document":"wk-form4_1771978411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2037272/000162828026011331/wk-form4_1771978411.xml","form_type":"4"}},{"id":897466,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":42482,"kind":"person","name":"Sabatini Brent","position":1,"cik":"0002037272","reported_name":"Sabatini Brent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Chief Accounting Officer"}}],"security":"Common  Stock","published_at":"2026-02-18T20:38:11.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":1530,"price":7.79,"value":11918.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an automatic and mandatory sale of shares under a  Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,290 and 485 shares of common stock acquired by the Reporting Person on May 30, 2025 and November 28, 2025, respectively, pursuant to an employee stock purchase program."}],"balance_after":47872,"source":{"system":"sec-edgar","filing":"0001628280-26-008984","document":"wk-form4_1771447089.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2037272/000162828026008984/wk-form4_1771447089.xml","form_type":"4"}},{"id":1246964,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":42482,"kind":"person","name":"Sabatini Brent","position":1,"cik":"0002037272","reported_name":"Sabatini Brent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Chief Accounting Officer"}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2025-02-25T20:37:21.000Z","date":"2025-02-22","kind":"grant","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":40000,"derivative":{"exercise_price":9.57,"expiration_date":"2035-02-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001628280-25-007696","document":"wk-form4_1740515835.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2037272/000162828025007696/wk-form4_1740515835.xml","form_type":"4"}},{"id":1246963,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":42482,"kind":"person","name":"Sabatini Brent","position":1,"cik":"0002037272","reported_name":"Sabatini Brent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Chief Accounting Officer"}}],"security":"Common  Stock","published_at":"2025-02-25T20:37:21.000Z","date":"2025-02-24","kind":"sale","planned":true,"acquired":false,"shares":1562,"price":9.4534,"value":14766.2108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."}],"balance_after":46627,"source":{"system":"sec-edgar","filing":"0001628280-25-007696","document":"wk-form4_1740515835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2037272/000162828025007696/wk-form4_1740515835.xml","form_type":"4"}},{"id":1246962,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":42482,"kind":"person","name":"Sabatini Brent","position":1,"cik":"0002037272","reported_name":"Sabatini Brent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Chief Accounting Officer"}}],"security":"Common  Stock","published_at":"2025-02-25T20:37:21.000Z","date":"2025-02-22","kind":"grant","planned":true,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":48189,"source":{"system":"sec-edgar","filing":"0001628280-25-007696","document":"wk-form4_1740515835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2037272/000162828025007696/wk-form4_1740515835.xml","form_type":"4"}},{"id":1267761,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":42482,"kind":"person","name":"Sabatini Brent","position":1,"cik":"0002037272","reported_name":"Sabatini Brent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Chief Accounting Officer"}}],"security":"Common  Stock","published_at":"2025-02-14T23:41:53.000Z","date":"2025-02-13","kind":"sale","planned":true,"acquired":false,"shares":1562,"price":9.1494,"value":14291.3628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects ownership after acquisition by the reporting person on November 29, 2024 of 1,312 shares of common stock pursuant to the Issuer's employee stock purchase program."}],"balance_after":28189,"source":{"system":"sec-edgar","filing":"0001628280-25-005864","document":"wk-form4_1739576505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2037272/000162828025005864/wk-form4_1739576505.xml","form_type":"4"}}]}